Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

21 March 2018

In April 2016 BioViva USA Inc. published a press release stating that Elizabeth Parrish, CEO, had experienced telomere lengthening in her leukocytes, as a result of an injection of two experimental therapies. These consisted of a myostatin inhibitor to protect against loss of muscle mass with age, and a telomerase inducer to battle stem cell depletion responsible for diverse age-related diseases and infirmities.

Leave a Reply

Your email address will not be published. Required fields are marked *